Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
24.07
-0.40 (-1.63%)
Apr 29, 2026, 1:54 PM EDT - Market open
Alto Neuroscience Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cash & Equivalents | 176.48 | 168.23 | 82.55 | 48.34 | 25.71 |
| Cash & Short-Term Investments | 176.48 | 168.23 | 82.55 | 48.34 | 25.71 |
| Cash Growth | 4.91% | 103.79% | 70.75% | 88.07% | - |
| Accounts Receivable | - | - | - | - | 1.5 |
| Other Receivables | - | - | - | 0.33 | 0.25 |
| Receivables | - | - | - | 0.33 | 1.74 |
| Prepaid Expenses | 1.23 | 1.11 | 0.52 | 0.33 | 0.24 |
| Other Current Assets | - | - | 2.32 | 0.21 | - |
| Total Current Assets | 177.72 | 169.34 | 85.39 | 49.22 | 27.68 |
| Property, Plant & Equipment | 6.13 | 7.7 | 1.23 | 1.58 | 1.06 |
| Other Long-Term Assets | 0.84 | 0.5 | 0.01 | 0.06 | 0.05 |
| Total Assets | 184.69 | 177.54 | 86.63 | 50.85 | 28.79 |
| Accounts Payable | 1.88 | 1.58 | 1.07 | 1.61 | 0.6 |
| Accrued Expenses | 7.71 | 7.56 | 3.5 | 3.67 | 0.93 |
| Current Portion of Long-Term Debt | 0.59 | - | - | - | - |
| Current Portion of Leases | 1.15 | 0.87 | 0.13 | 0.28 | - |
| Other Current Liabilities | - | - | 0.92 | - | 0.28 |
| Total Current Liabilities | 11.33 | 10.01 | 5.61 | 5.56 | 1.81 |
| Long-Term Debt | 18.4 | 11.56 | 9.86 | 9.47 | - |
| Long-Term Leases | 3.82 | 4.52 | - | 0.12 | - |
| Total Liabilities | 33.55 | 26.08 | 15.47 | 15.15 | 1.81 |
| Common Stock | 0 | 0 | - | - | 0 |
| Additional Paid-In Capital | 352.75 | 289.95 | 5.37 | 2.3 | 0.49 |
| Retained Earnings | -201.63 | -138.4 | -76.97 | -40.66 | -12.95 |
| Comprehensive Income & Other | 0.02 | -0.1 | -0.08 | -0.05 | -0.02 |
| Total Common Equity | 151.14 | 151.46 | -71.67 | -38.41 | -12.48 |
| Shareholders' Equity | 151.14 | 151.46 | 71.16 | 35.71 | 26.98 |
| Total Liabilities & Equity | 184.69 | 177.54 | 86.63 | 50.85 | 28.79 |
| Total Debt | 23.96 | 16.94 | 9.99 | 9.87 | - |
| Net Cash (Debt) | 152.53 | 151.29 | 72.56 | 38.47 | 25.71 |
| Net Cash Growth | 0.82% | 108.49% | 88.61% | 49.67% | - |
| Net Cash Per Share | 5.29 | 6.15 | 19.45 | 11.16 | 10.65 |
| Filing Date Shares Outstanding | 31.95 | 27.07 | 26.86 | 3.69 | 2.41 |
| Total Common Shares Outstanding | 31.92 | 26.99 | 3.81 | 3.69 | 2.41 |
| Working Capital | 166.39 | 159.33 | 79.78 | 43.66 | 25.87 |
| Book Value Per Share | 4.73 | 5.61 | -18.81 | -10.40 | -5.17 |
| Tangible Book Value | 151.14 | 151.46 | -71.67 | -38.41 | -12.48 |
| Tangible Book Value Per Share | 4.73 | 5.61 | -18.81 | -10.40 | -5.17 |
| Machinery | 2.58 | 2.75 | 1.27 | 1.2 | 0.88 |
| Leasehold Improvements | 0.25 | 0.25 | - | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.